product name
美金胺 盐酸盐, ≥98% (GC)
质量水平
检测方案
≥98% (GC)
形式
powder
创始人
Forest Labs
SMILES字符串
Cl.C[C@]12CC3C[C@](C)(C1)CC(N)(C3)C2
InChI
1S/C12H21N.ClH/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10;/h9H,3-8,13H2,1-2H3;1H/t9-,10+,11-,12-;
InChI key
LDDHMLJTFXJGPI-VXMZOEJHSA-N
基因信息
human ... DRD1(1812) , DRD2(1813) , DRD3(1814) , DRD4(1815) , DRD5(1816)
正在寻找类似产品? 访问 产品对比指南
应用
盐酸美金刚用作：
- 培养基的补充剂，作为对照，在N-甲基-D-天冬氨酸受体诱导毒性的条件下，研究促红细胞生成素的神经保护作用
- 腹腔注射实验动物，研究其对创伤的影响
- 作为试验化合物，确定穿透视网膜色素上皮组织的动态范围和选择性
生化/生理作用
低亲和力 NMDA 谷氨酸受体拮抗剂；刺激多巴胺释放。
美金刚对阿尔茨海默氏病和帕金森氏病有效。 也可用于治疗癫痫、运动神经元疾病和创伤。
特点和优势
该化合物是受体分类及信号转导手册上谷氨酸受体（离子通道家族）页面上的特色化合物。想要浏览手册的其他页面， 请单击此处。
该化合物由森林实验室(Forest Labs)开发。要浏览其他药物开发化合物和批准的药物/候选药物列表，单击此处。
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
Eyeshields, Gloves, type N95 (US)
Anton N Shuvaev et al.
International journal of molecular sciences, 22(15) (2021-08-08)
Spinocerebellar ataxias are a family of fatal inherited diseases affecting the brain. Although specific mutated proteins are different, they may have a common pathogenetic mechanism, such as insufficient glutamate clearance. This function fails in reactive glia, leading to excitotoxicity and
C G Parsons et al.
Neuropharmacology, 32(12), 1337-1350 (1993-12-01)
Memantine (1-amino-3,5-dimethyladamantan) was tested as an antagonist of N-methyl-D-aspartate (NMDA) receptors on cultured superior collicular and hippocampal neurones using the patch clamp technique and its actions were compared to those of Mg2+ ions, ketamine, dextrorphan, dextromethorphan, phencyclidine and dizocilpine (MK-801).
M Weller et al.
Brain research, 613(1), 143-148 (1993-06-04)
Effects of amantadine and memantine on NMDA receptor-mediated glutamate toxicity were studied in cultured cerebellar, cortical and mesencephalic neurons. Both drugs protected cerebellar and cortical neurons against glutamate toxicity, memantine being consistently more effective than amantadine but less effective than
Dementia of Alzheimer?s disease and other neurodegenerative disorders-memantine, a new hope
Sonkusare SK, et al.
Pharmacological Research, 51(1), 1-17 (2005)
Anton N Shuvaev et al.
Brain sciences, 12(4) (2022-04-22)
Memantine is an FDA approved drug for the treatment of Alzheimer's disease. It reduces neurodegeneration in the hippocampus and cerebral cortex through the inhibition of extrasynaptic NMDA receptors in patients and mouse models. Potentially, it could prevent neurodegeneration in other
商品
Discover Bioactive Small Molecules for ADME/Tox
DISCOVER Bioactive Small Molecules for Neuroscience
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门